Skip to main content
Jinyu Bio-Technology Co.,Ltd. logo

Jinyu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 600201 ISIN · CNE000000Y37 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,777 across all filing types
Latest filing 2017-04-24 Audit Report / Informat…
Country CN China
Listing Shanghai Stock Exchange 600201

About Jinyu Bio-Technology Co.,Ltd.

http://jinyubiotech.com/

Jinyu Bio-Technology Co., Ltd. focuses on the research, development, and manufacturing of veterinary biological products and pharmaceuticals. The company is a prominent supplier of animal vaccines, particularly specializing in Foot-and-Mouth Disease (FMD) vaccines, brucellosis vaccines, and solutions for swine and poultry diseases. It utilizes advanced biotechnology platforms, including large-scale suspension culture and high-efficiency purification processes, to produce high-titer, high-purity biologicals. The organization operates sophisticated research facilities and Biosafety Level 3 (P3) laboratories to support the development of diagnostic reagents and preventive treatments. Its operations center on enhancing animal health through scientific innovation, providing comprehensive disease control strategies for the global livestock industry and large-scale agricultural operations.

Recent filings

Filing Released Lang Actions
募集资金年度存放与使用情况鉴证报告（2016年度）
Audit Report / Information Classification · 95% confidence The document is a detailed report titled '募集资金年度存放与使用情况鉴证报告 2016年度' which translates to 'Annual Verification Report on the Storage and Use of Raised Funds for 2016'. It is issued by an accounting firm (立信会计师事务所) and addresses the shareholders of the company. The report includes detailed information about the raised funds, their management, usage, and compliance with regulatory requirements. It references specific regulatory guidelines from the China Securities Regulatory Commission and the Shanghai Stock Exchange regarding the management and use of raised funds. The document contains financial figures, audit opinions, and detailed tables about the use of the raised funds during the fiscal year 2016. This type of report is a specialized audit or verification report focusing on the use of capital raised by the company, which fits the definition of an Audit Report / Information (AR) rather than a full Annual Report (10-K) or a simple announcement. The document length is substantial (15,000 characters), and it contains substantive financial and compliance information, not just an announcement or certification. Therefore, the correct classification is AR with high confidence.
2017-04-24 Chinese
东北证券股份有限公司关于金宇生物技术股份有限公司使用部分闲置募集资金进行现金管理的核查意见
Capital/Financing Update Classification · 95% confidence The document is a detailed verification opinion from a sponsoring institution regarding the use of idle raised funds by a company for cash management purposes. It references regulatory guidelines on the management and use of raised funds, details the amount, investment products, risk control measures, and approvals by the board and independent directors. It does not contain financial statements or quarterly/yearly financial results but focuses on the use of raised capital and compliance with regulations. This fits the category of a Capital/Financing Update (CAP), as it updates on the company's use of fundraising proceeds for cash management.
2017-04-24 Chinese
东北证券股份有限公司关于《金宇生物技术股份有限公司2017年度限制性股票股权激励计划（草案）》之独立财务顾问报告
Audit Report / Information Classification · 95% confidence The document is an Independent Financial Advisor Report related to a 2017 restricted stock equity incentive plan for a company. It contains detailed sections on definitions, statements, assumptions, main content of the incentive plan, and the independent financial advisor's opinions on the plan's compliance with laws, feasibility, scope, equity limits, financial support, and impact on shareholders and company performance. The document is lengthy (15,000 characters) and includes substantive financial and legal analysis related to the equity incentive plan. It is not a general annual report, earnings release, or a simple announcement. It is a specialized report providing audit-like opinions on a specific equity incentive plan, which fits the category of an Audit Report / Information (AR) rather than a full Annual Report (10-K) or other categories. Therefore, the correct classification is AR with high confidence.
2017-04-24 Chinese
内部控制审计报告（2016年度）
Audit Report / Information Classification · 95% confidence The document is titled '内部控制审计报告 2016年度' which translates to 'Internal Control Audit Report for the year 2016'. It is issued by a registered accounting firm (BDO 立信会计师事务所) and addresses the effectiveness of internal controls over financial reporting as of December 31, 2016. The content includes auditor responsibilities, company responsibilities, and an audit opinion on internal control effectiveness. This matches the description of an Audit Report / Information (AR), which includes standalone audit reports and applied accounting principles related to internal controls. The document length is 2252 characters, which is relatively short but contains substantive audit content rather than just an announcement or certification. Therefore, it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS). Hence, the correct classification is AR with high confidence.
2017-04-24 Chinese
募集资金年度存放与使用情况鉴证报告（2016年度）
Audit Report / Information Classification · 95% confidence The document is a detailed report titled '募集资金年度存放与使用情况鉴证报告 2016年度' which translates to 'Annual Verification Report on the Storage and Use of Raised Funds for 2016'. It is issued by an accounting firm (立信会计师事务所) and addresses the shareholders of the company 金宇生物技术股份有限公司. The report discusses the management, storage, and actual use of funds raised through a non-public stock issuance in 2016, including compliance with regulatory requirements from the China Securities Regulatory Commission and the Shanghai Stock Exchange. It includes detailed financial figures, audit opinions, and a table of fund usage. The document is not merely an announcement but contains substantive financial data and an auditor's verification, indicating it is a standalone audit-related report on the use of raised capital. This fits the definition of an Audit Report / Information (AR) rather than a full Annual Report (10-K) or a simple announcement (RPA).
2017-04-24 Chinese
监事会关于会计政策变更的说明
Audit Report / Information Classification · 95% confidence The document is a statement from the Supervisory Board regarding a change in accounting policy related to VAT accounting treatment as per a Ministry of Finance regulation. It discusses the rationale, impact on financial statement line items, and confirms compliance with legal and regulatory requirements. The document does not contain full financial statements or comprehensive financial performance data, nor is it an announcement of a report publication. It is a standalone explanation of an accounting policy change, which fits the category of Audit Report / Information (AR) as it relates to accounting principles and their application.
2017-04-24 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.